Fernando Ulloa Montoya
Head mRNA Data and Computational Sciences, Sanofi
Sanofi
Tervuren, Belgium
12 profile visitsSpeakerSpeaker
About me
My organisation
Sanofi
Sanofi
Additional questions
How would you categorise yourself?
Vaccine manufacturerHigher management
Organisation Type
Pharma industry
Areas of expertise
Personalised medicineDigital health and technologyResearch and developmentImmunotherapy R&DVaccine R&D
Therapeutic areas
Infectious diseases Oncology
1. I accept the General Terms & Conditions and Privacy Statement, available on flandersvaccine.be and agree that pictures can be taken at the event and be used for Flanders Vaccine communication purposes.
I agreeSpeaker sessions (2)
Thursday, 17 October 2024
10:10 - 10:35
The use of Artificial Intelligence and Machine Learning (AI/ML) in the development of mRNA vaccines - Fernando Ulloa Montoya, Sanofi
Format:In-person
AI&ML and mechanistic modeling allow us to tackle the complex combinatorial problem of mRNA sequence, lipid nano-particles design and process development to optimize critical quality attributes and immune response of mRNA vaccines
16:00 - 16:40
Panel discussion: The future of Immunotherapy & Vaccines R&D
Format:In-person